ATsens Co., Ltd. news

AT-Patch is distributed to domestic clinics through Hanmi Pharmaceutical Co., Ltd.  Expect to expand ATsens` product line with this Strategic MOU

https://www.pharmnews.com/news/articleView.html?idxno=209620

• ATsens is recently awarded by NHS Supply Chain as on of suppliers for long-term continuous ECG monitor `AT-Patch`.
• It is believed to be recognition of new technology and competitiveness which can bring good value to NHS services.
• ATsens is now qualified to supply AT-Patch directly to NHS Trust Hospitals and its customers, around 1,978 NHS-registered bases. 
  

• ATsens developed the first wearable long-term continuous ECG monitor in Korea.
• Honorary professor Lee Man-Yeong was appointed as CMO and head of the data center for medical advice and data center establishment.
• He’s a professor of Circulatory Internal Medicine and an authority in the field of arrhythmia, who continued research and treatment of arrhythmia during his tenure.
• Participate in establishing an analysis center, a new business model, and upgr

• ‘ATP-C70’, wearable ECG monitor of ATsens starts prescribing at Sejong Chungnam National University Hospital.
• It’s an extension of the smart ward platform business and is introduced into Korea`s first smart outpatient treatment program.
• It will support accurate vital sign measurement and customized diagnosis of arrhythmia patients through AT Patch, which can measure ECG for three to seven consecutive days.